SCHEMBL29757356

SCHEMBL29757356

CC(C)c1c(F)c(F)cc(-c2ccnc(F)c2)c1CC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 9/20 0.40
DHODH Q02127 1/20 0.38
CYP3A4 P08684 1/20 0.34
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
FPR2 P25090 1/20 0.33
WNT3A P56704 2/20 0.32
TLR9 Q9NR96 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
ROCK2 O75116 1/20 0.32
CYP2C9 P11712 1/20 0.32
PRKACA P17612 1/20 0.32
PRKACG P22612 1/20 0.32
PRKACB P22694 1/20 0.32
AKT1 P31749 1/20 0.32
ROCK1 Q13464 1/20 0.32
PRKG1 Q13976 1/20 0.32
APP P05067 1/20 0.31
TBK1 Q9UHD2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29691328 1.00 AAK1 (0.40) AAK1DHODHCYP3A4MTNR1AMTNR1B
SCHEMBL23012881 1.00 AAK1 (0.40) AAK1DHODHCYP3A4MTNR1AMTNR1B
SCHEMBL29691355 0.89 AAK1 (0.39) AAK1DHODHCYP3A4MTNR1AMTNR1B
SCHEMBL23012397 0.89 AAK1 (0.39) AAK1DHODHCYP3A4MTNR1AMTNR1B
SCHEMBL29757358 0.89 AAK1 (0.38) AAK1DHODHMTNR1AMTNR1BTLR9
SCHEMBL23013017 0.89 AAK1 (0.38) AAK1DHODHMTNR1AMTNR1BTLR9
SCHEMBL29691511 0.89 AAK1 (0.38) AAK1DHODHMTNR1AMTNR1BTLR9
SCHEMBL23012438 0.87 AAK1 (0.39) AAK1DHODHCYP3A4MTNR1AMTNR1B
SCHEMBL23012442 0.87 AAK1 (0.41) AAK1DHODHWNT3A
SCHEMBL23012491 0.87 AAK1 (0.37) AAK1DHODHCYP3A4MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013762-A1 MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS Inflazome Limited (IE) 2022-06-22 EP disclosed